MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ATXS has $271,866K in assets. $38,613K in debts. $96,280K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1078.14%
Cash Ratio
409.41%
Debt to Asset Ratio
14.20%
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Preferred stock-Series XRedeemab...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
96,280 76,319
Short-term investments
131,441 182,859
Accounts receivable
17,243 -
Prepaid expenses and other current assets
8,582 9,408
Total current assets
253,546 268,586
Right-of-use asset
4,254 4,546
Other assets
14,066 8,792
Total assets
271,866 281,924
Accounts payable
1,137 738
Accrued expenses
16,481 15,907
Operating lease liabilities, current
1,404 1,399
Deferred revenue, current
4,495 -
Total current liabilities
23,517 18,044
Operating lease liabilities, net of current portion
3,055 3,367
Deferred revenue, net of current portion
12,041 -
Preferred stock-Nonredeemable Preferred Stock
-0
Total liabilities
38,613 21,411
Preferred stock-Series XRedeemable Convertible Preferred Stock
95,324 95,324
Common stock, 0.001 par value per share, 150,000,000 shares authorized 56,434,894 and 56,434,219 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
57 57
Additional paid-in capital
911,014 906,703
Accumulated other comprehensive gain
56 -16
Accumulated deficit
-773,198 -741,555
Total stockholders' equity
233,253 260,513
Total liabilities and stockholders' equity
271,866 281,924
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$8,582K Accounts receivable$17,243K Short-term investments$131,441K Cash and cashequivalents$96,280K Other assets$14,066K Right-of-use asset$4,254K Total current assets$253,546K Total assets$271,866K Total liabilities andstockholders' equity$271,866K Total stockholders'equity$233,253K Total liabilities$38,613K Accumulated deficit-$773,198K Accumulated othercomprehensive gain$56K Additional paid-in capital$911,014K Deferred revenue, net ofcurrent portion$12,041K Operating leaseliabilities, net of current...$3,055K Total currentliabilities$23,517K Common stock, 0.001 parvalue per share,...$57K Preferred stock-SeriesXRedeemable Convertible...$95,324K Deferred revenue,current$4,495K Operating leaseliabilities, current$1,404K Accrued expenses$16,481K Accounts payable$1,137K

Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics, Inc. (ATXS)